REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot1352Original ArticleMacroeconomic preconditions for the development of pharmaceutical market in the medium-term perspectiveTrofimovaE. O.noemail@neicon.ruSt. Petersburg State Chemical and Pharmaceutical University1512201813S203118032022Copyright © 2018,2018In 2017, the Russian economy emerged from the recession, and it is expected to grow in the medium term. The risks for its growth are created by the foreign policy crisis, anti-Russian sanctions, energy price volatility. The projected low growth rates of household incomes will create restrictions for the growth of the commercial part of the pharmaceutical market. Healthcare is one of the priorities of the country's socioeconomic development for the new presidential term, which is fundamentally important for solving the country's demographic and socio-economic problems. In this situation, the most problematic areas of drug provision can expect an increase in funding out of the government sources. However, measures aimed at improving the economic efficiency of public procurements will be of no less importance for solving these tasks. a 15% increase in consolidated health care expenditures is planned in 2018, largely due to the electoral cycle and the need to implement the President's May decrees. According to the adopted budgets, the growth rate is planned at the level of forecast inflation in 2019-2020. At the same time, the health sector should receive higher funding as follows from the statements of the government, when working on a new three-year federal budget.pharmaceutical marketфармацевтический рынок